Tag Archives: Real-Time Oncology Review

Roche on Tecentriq’s US FDA Priority Review grant: New treatment options are urgently needed in early-stage non-small cell lung cancer

Posted on 3, August 2021 by

Application is being reviewed under the US FDA’s Real-Time Oncology Review pilot programme Based on results of the Phase III IMpower010 study, presented at ASCO, that showed adjuvant Tecentriq improved disease-free survival by more than one-third in PD-L1-positive early-stage lung cancer, compared with … Read the full press release →

Posted in Healthcare, Marketing, News, Pharma & Biotech, Switzerland

Tagged , , , , , , , , , , , , , ,